Back

IRONMAN: Effect of intravenous iron according to age

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Iain B Squire

University of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Dapagliflozin and PAD in HF
Doctor J. Butt (Copenhagen, DK)
Slides Video
Presentation thumbnail
FINEARTS-HF: Design and Baseline Characteristics
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
Reasons for hospitalisation and mode of death for patients with heart failure and iron deficiency in the IRONMAN randomized trial.
Professor J. Cleland (Glasgow, GB)
Slides Video
Presentation thumbnail
IRONMAN: anaemia, iron deficiency and quality of life in heart failure and its response to IV iron
Professor P. Kalra (Portsmouth, GB)
Slides Video
Presentation thumbnail
IRONMAN: Which marker of iron deficiency best predicts response to intravenous iron in patients with heart failure?
Professor J. Cleland (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials
Video

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources